An epigenetic spin to ALS and FTD

Mark T.W. Ebbert, Rebecca J. Lank, Veronique Belzil

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating and lethal neurodegenerative diseases seen comorbidly in up to 15% of patients. Despite several decades of research, no effective treatment or disease-modifying strategies have been developed. We now understand more than before about the genetics and biology behind ALS and FTD, but the genetic etiology for the majority of patients is still unknown and the phenotypic variability observed across patients, even those carrying the same mutation, is enigmatic. Additionally, susceptibility factors leading to neuronal vulnerability in specific central nervous system regions involved in disease are yet to be identified. As the inherited but dynamic epigenome acts as a cell-specific interface between the inherited fixed genome and both cell-intrinsic mechanisms and environmental input, adaptive epigenetic changes might contribute to the ALS/FTD aspects we still struggle to comprehend. This chapter summarizes our current understanding of basic epigenetic mechanisms, how they relate to ALS and FTD, and their potential as therapeutic targets. A clear understanding of the biological mechanisms driving these two currently incurable diseases is urgent—well-needed therapeutic strategies need to be developed soon. Disease-specific epigenetic changes have already been observed in patients and these might be central to this endeavor.

Original languageEnglish (US)
Title of host publicationAdvances in Neurobiology
PublisherSpringer New York LLC
Pages1-29
Number of pages29
DOIs
StatePublished - Jan 1 2018

Publication series

NameAdvances in Neurobiology
Volume20
ISSN (Print)2190-5215

Fingerprint

Epigenomics
Neurodegenerative diseases
Neurology
Neurodegenerative Diseases
Therapeutics
Central Nervous System
Genes
Genome
Mutation
Frontotemporal Dementia With Motor Neuron Disease
Research

Keywords

  • Amyotrophic lateral sclerosis
  • Epigenetic modifications
  • Frontotemporal dementia
  • Methylation
  • RNA-mediated regulation

ASJC Scopus subject areas

  • Biochemistry
  • Neurology
  • Developmental Neuroscience
  • Cellular and Molecular Neuroscience

Cite this

Ebbert, M. T. W., Lank, R. J., & Belzil, V. (2018). An epigenetic spin to ALS and FTD. In Advances in Neurobiology (pp. 1-29). (Advances in Neurobiology; Vol. 20). Springer New York LLC. https://doi.org/10.1007/978-3-319-89689-2_1

An epigenetic spin to ALS and FTD. / Ebbert, Mark T.W.; Lank, Rebecca J.; Belzil, Veronique.

Advances in Neurobiology. Springer New York LLC, 2018. p. 1-29 (Advances in Neurobiology; Vol. 20).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ebbert, MTW, Lank, RJ & Belzil, V 2018, An epigenetic spin to ALS and FTD. in Advances in Neurobiology. Advances in Neurobiology, vol. 20, Springer New York LLC, pp. 1-29. https://doi.org/10.1007/978-3-319-89689-2_1
Ebbert MTW, Lank RJ, Belzil V. An epigenetic spin to ALS and FTD. In Advances in Neurobiology. Springer New York LLC. 2018. p. 1-29. (Advances in Neurobiology). https://doi.org/10.1007/978-3-319-89689-2_1
Ebbert, Mark T.W. ; Lank, Rebecca J. ; Belzil, Veronique. / An epigenetic spin to ALS and FTD. Advances in Neurobiology. Springer New York LLC, 2018. pp. 1-29 (Advances in Neurobiology).
@inbook{7a7983d0c54641a1b7b4705f0f647b0b,
title = "An epigenetic spin to ALS and FTD",
abstract = "Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating and lethal neurodegenerative diseases seen comorbidly in up to 15{\%} of patients. Despite several decades of research, no effective treatment or disease-modifying strategies have been developed. We now understand more than before about the genetics and biology behind ALS and FTD, but the genetic etiology for the majority of patients is still unknown and the phenotypic variability observed across patients, even those carrying the same mutation, is enigmatic. Additionally, susceptibility factors leading to neuronal vulnerability in specific central nervous system regions involved in disease are yet to be identified. As the inherited but dynamic epigenome acts as a cell-specific interface between the inherited fixed genome and both cell-intrinsic mechanisms and environmental input, adaptive epigenetic changes might contribute to the ALS/FTD aspects we still struggle to comprehend. This chapter summarizes our current understanding of basic epigenetic mechanisms, how they relate to ALS and FTD, and their potential as therapeutic targets. A clear understanding of the biological mechanisms driving these two currently incurable diseases is urgent—well-needed therapeutic strategies need to be developed soon. Disease-specific epigenetic changes have already been observed in patients and these might be central to this endeavor.",
keywords = "Amyotrophic lateral sclerosis, Epigenetic modifications, Frontotemporal dementia, Methylation, RNA-mediated regulation",
author = "Ebbert, {Mark T.W.} and Lank, {Rebecca J.} and Veronique Belzil",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-89689-2_1",
language = "English (US)",
series = "Advances in Neurobiology",
publisher = "Springer New York LLC",
pages = "1--29",
booktitle = "Advances in Neurobiology",

}

TY - CHAP

T1 - An epigenetic spin to ALS and FTD

AU - Ebbert, Mark T.W.

AU - Lank, Rebecca J.

AU - Belzil, Veronique

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating and lethal neurodegenerative diseases seen comorbidly in up to 15% of patients. Despite several decades of research, no effective treatment or disease-modifying strategies have been developed. We now understand more than before about the genetics and biology behind ALS and FTD, but the genetic etiology for the majority of patients is still unknown and the phenotypic variability observed across patients, even those carrying the same mutation, is enigmatic. Additionally, susceptibility factors leading to neuronal vulnerability in specific central nervous system regions involved in disease are yet to be identified. As the inherited but dynamic epigenome acts as a cell-specific interface between the inherited fixed genome and both cell-intrinsic mechanisms and environmental input, adaptive epigenetic changes might contribute to the ALS/FTD aspects we still struggle to comprehend. This chapter summarizes our current understanding of basic epigenetic mechanisms, how they relate to ALS and FTD, and their potential as therapeutic targets. A clear understanding of the biological mechanisms driving these two currently incurable diseases is urgent—well-needed therapeutic strategies need to be developed soon. Disease-specific epigenetic changes have already been observed in patients and these might be central to this endeavor.

AB - Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating and lethal neurodegenerative diseases seen comorbidly in up to 15% of patients. Despite several decades of research, no effective treatment or disease-modifying strategies have been developed. We now understand more than before about the genetics and biology behind ALS and FTD, but the genetic etiology for the majority of patients is still unknown and the phenotypic variability observed across patients, even those carrying the same mutation, is enigmatic. Additionally, susceptibility factors leading to neuronal vulnerability in specific central nervous system regions involved in disease are yet to be identified. As the inherited but dynamic epigenome acts as a cell-specific interface between the inherited fixed genome and both cell-intrinsic mechanisms and environmental input, adaptive epigenetic changes might contribute to the ALS/FTD aspects we still struggle to comprehend. This chapter summarizes our current understanding of basic epigenetic mechanisms, how they relate to ALS and FTD, and their potential as therapeutic targets. A clear understanding of the biological mechanisms driving these two currently incurable diseases is urgent—well-needed therapeutic strategies need to be developed soon. Disease-specific epigenetic changes have already been observed in patients and these might be central to this endeavor.

KW - Amyotrophic lateral sclerosis

KW - Epigenetic modifications

KW - Frontotemporal dementia

KW - Methylation

KW - RNA-mediated regulation

UR - http://www.scopus.com/inward/record.url?scp=85048961560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048961560&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-89689-2_1

DO - 10.1007/978-3-319-89689-2_1

M3 - Chapter

C2 - 29916014

AN - SCOPUS:85048961560

T3 - Advances in Neurobiology

SP - 1

EP - 29

BT - Advances in Neurobiology

PB - Springer New York LLC

ER -